Tony Huge

Sleep Apnea Screening: The Missed Diagnosis in Lifters

Table of Contents

Quick Summary

  • Obstructive sleep apnoea is common, under-diagnosed, and disproportionately affects exactly the phenotype this site is written for: large, thick-necked, heavily muscled men.
  • Peppard and colleagues documented substantially higher prevalence than earlier estimates, tracking the rise in body mass across the population.
  • Untreated apnoea drives hypertension, raises hematocrit through nocturnal hypoxia, worsens insulin resistance, and suppresses the nocturnal growth hormone and testosterone pulses that recovery depends on.
  • Testosterone therapy can worsen apnoea severity, creating a loop in which the treatment for low energy aggravates a cause of it.
  • STOP-Bang is a validated eight-item screening tool. It does not diagnose, but it identifies who should have a sleep study.

A man comes in tired. His testosterone is low-normal, his hematocrit is creeping up, his blood pressure is higher than it should be, his morning erections have become unreliable and he cannot lose the last stone regardless of what he does with his diet. The standard response in this world is a hormone panel and a protocol. The more likely explanation, in a heavily muscled man with a 45-centimetre neck who snores loudly enough to be exiled to another room, is that he stops breathing dozens of times an hour every night and nobody has ever asked.

What Obstructive Sleep Apnoea Is

During sleep, muscle tone in the upper airway falls. In susceptible people the pharyngeal airway collapses, partially or completely, obstructing airflow despite continued respiratory effort. Oxygen saturation drops, carbon dioxide rises, and the resulting chemoreceptor stimulus triggers a brief cortical arousal that restores tone and reopens the airway. The person rarely remembers any of it. The cycle repeats, sometimes hundreds of times per night.

The consequences follow from two things: fragmented sleep architecture and intermittent hypoxia. Fragmentation destroys the deep slow-wave sleep in which most physical recovery occurs. Intermittent hypoxia drives sympathetic activation, oxidative stress, endothelial dysfunction and erythropoietin release. Neither of these is compatible with recovery, body composition goals, or cardiovascular longevity.

Peppard and colleagues re-estimated prevalence in a community cohort and found figures considerably above earlier estimates, with moderate to severe sleep-disordered breathing affecting a substantial minority of middle-aged men. More recent modelling work projecting the future burden in the United States reinforces that this is a growing problem tracking population body mass.

Why This Population Is High Risk

The anatomical risk factors read like a description of a competitive strength athlete. Large neck circumference is one of the strongest predictors, and it does not distinguish between fat and muscle: mass around the airway is mass around the airway, and heavily developed sternocleidomastoids, scalenes and upper trapezius contribute. High body mass, whether from adiposity or lean tissue, raises risk. Male sex roughly doubles it.

Layered on top are factors specific to enhancement. Fluid retention from androgens and from high sodium intake contributes to upper airway oedema. Substantial weight gained in an off-season increases loading regardless of composition. And testosterone therapy itself has been shown to worsen breathing during sleep: Hoyos and colleagues found that testosterone therapy in obese men with severe obstructive sleep apnoea worsened measures of sleep-disordered breathing, and Killick and colleagues examined its effects on ventilatory responses in a placebo-controlled design.

That creates a genuinely vicious loop. Untreated apnoea suppresses testosterone, because the majority of the nocturnal testosterone pulse occurs during consolidated sleep and fragmented sleep blunts it. The man presents with low testosterone and fatigue. He receives testosterone. The apnoea worsens. His hematocrit rises further, his blood pressure rises further, and the underlying disease goes untreated while the symptom is medicated.

The Downstream Markers

Marker How apnoea moves it Why this matters
Hematocrit and haemoglobin Nocturnal hypoxia stimulates erythropoietin A common and frequently missed cause of erythrocytosis that gets blamed entirely on testosterone. Treating the apnoea often lowers hematocrit.
Blood pressure Sympathetic activation and loss of nocturnal dipping Apnoea is one of the leading identifiable causes of resistant hypertension. Non-dipping nocturnal pressure is a specific clue.
Fasting glucose and insulin Sleep fragmentation impairs insulin sensitivity Explains stubborn body composition despite disciplined nutrition.
Testosterone Fragmented sleep blunts the nocturnal pulse Low testosterone can be a consequence rather than a cause, and may partly reverse with apnoea treatment.
Growth hormone Slow-wave sleep is when the largest GH pulse occurs Directly undermines recovery, which is the reason many people are taking anything at all.
Resting heart rate and HRV Persistent sympathetic dominance Often visible on a wearable as poor overnight recovery scores despite adequate time in bed.

The wearable point is practically useful. A device showing consistently elevated overnight resting heart rate, suppressed heart rate variability, and low deep sleep despite eight hours in bed is not a reason to buy a supplement. It is a reason to get screened.

STOP-Bang

Chung and colleagues developed and validated the STOP questionnaire and its expanded STOP-Bang form, which has become the most widely used screening instrument in the field. The eight items are snoring loudly, tiredness during the day, observed stopping of breathing, high blood pressure, body mass index above 35, age over 50, neck circumference above roughly 40 centimetres, and male sex.

Each affirmative answer scores one point. Higher scores indicate higher probability of moderate to severe apnoea. The instrument was designed for high sensitivity, meaning it deliberately over-identifies in order to miss as few cases as possible, and it is a screening tool rather than a diagnostic one. A positive screen means a sleep study is warranted.

Note how many items a large male strength athlete scores automatically. Male sex, neck circumference, and often blood pressure are three points before any symptom is considered. This is a population in which the tool will flag a lot of people, and that is appropriate rather than a flaw.

Diagnosis and Treatment

Diagnosis requires a sleep study, either an in-laboratory polysomnogram or a home sleep apnoea test, which quantifies the apnoea-hypopnoea index and oxygen desaturation. Home testing has made this far more accessible than it was a decade ago.

Continuous positive airway pressure remains the most effective treatment for moderate to severe disease, and adherence is the main determinant of benefit. Modern machines and masks are considerably better tolerated than their reputation suggests. Alternatives depending on severity and anatomy include mandibular advancement devices, positional therapy for those whose events are supine-predominant, weight loss where adiposity is a driver, surgical options, and hypoglossal nerve stimulation in selected patients. Alcohol and sedatives worsen events and are worth addressing regardless.

People who treat significant apnoea successfully frequently describe the change in recovery, training quality and mood as larger than anything they have obtained pharmacologically. That is not a rhetorical flourish; restoring several hours of deep sleep per night to someone who has not had it in years is a substantial intervention.

The Framing

Under the Tony Huge Laws of Biochemistry Physics, this is the chain bottleneck in its purest form. You can optimise every accelerator you can name, and if you spend every night in intermittent hypoxia with fragmented sleep architecture, the bottleneck is upstream of all of it. Growth hormone secretion, testosterone production, insulin sensitivity, blood pressure and red cell mass all pass through that single constricted link.

Screening costs nothing but eight honest answers. Diagnosis costs a home test. The failure mode is a man who spends a decade and considerable money chasing the downstream markers, adjusting protocols, watching his hematocrit climb and his blood pressure with it, while the actual problem sits unexamined every night between eleven and seven.

Where This Fits in the Bigger Picture

Monitoring is the part of enhancement that nobody posts about, and it is the part that decides how long you get to keep doing this. Testing gives you a feedback loop; without one you are guessing with your organs. Start with the Enhanced Athlete Protocol bloodwork guide, then work through the full protocol hub to see how testing, training, nutrition and recovery connect. If you are early in this, the beginners page is the right entry point.

See the recovery pillar for the broader sleep architecture discussion.

Frequently Asked Questions

What is the STOP-Bang questionnaire?

STOP-Bang is a validated eight-item screening tool for obstructive sleep apnoea. It asks about loud snoring, daytime tiredness, observed pauses in breathing, high blood pressure, body mass index above 35, age over 50, neck circumference above roughly 40 centimetres, and male sex. Each yes scores a point, and higher totals indicate a higher probability of moderate to severe apnoea. It screens rather than diagnoses; a positive result means a sleep study is warranted.

Can sleep apnea cause high hematocrit?

Yes. Repeated drops in blood oxygen during the night stimulate erythropoietin release, which increases red cell production. This is a well-recognised and frequently overlooked cause of raised hematocrit, and in people also using testosterone it is often incorrectly attributed entirely to the hormone. Treating the apnoea can lower hematocrit substantially.

Does testosterone make sleep apnea worse?

Published randomised research has found that testosterone therapy worsened measures of sleep-disordered breathing in obese men with severe obstructive sleep apnoea, at least in the short term. Because untreated apnoea also lowers testosterone by disrupting the nocturnal hormone pulse, the two conditions can reinforce one another, which is a strong argument for screening before and during therapy.

Are muscular men at risk of sleep apnea?

Large neck circumference is one of the strongest anatomical predictors, and it reflects total mass around the airway rather than fat specifically, so well-developed neck and upper back musculature contributes. Combined with male sex, high body mass and the fluid retention associated with some compounds, strength athletes are a higher-risk group than their fitness level might suggest.

Who should be screened for sleep apnea?

Anyone who snores loudly, has been observed to stop breathing during sleep, feels unrefreshed despite adequate time in bed, or has unexplained daytime sleepiness should be screened. Screening is also reasonable for people with resistant high blood pressure, unexplained raised hematocrit, or a large neck circumference, and for anyone considering or already using testosterone therapy.


References

  1. Chung F, et al. “STOP questionnaire: a tool to screen patients for obstructive sleep apnea.” Anesthesiology, 2008. doi:10.1097/ALN.0b013e31816d83e4 (PMID 18431116)
  2. Chung F, et al. “STOP-Bang Questionnaire: A Practical Approach to Screen for Obstructive Sleep Apnea.” Chest, 2016. doi:10.1378/chest.15-0903 (PMID 26378880)
  3. Peppard PE, et al. “Increased prevalence of sleep-disordered breathing in adults.” Am J Epidemiol, 2013. doi:10.1093/aje/kws342 (PMID 23589584)
  4. Hoyos CM, et al. “Effects of testosterone therapy on sleep and breathing in obese men with severe obstructive sleep apnoea: a randomized placebo-controlled trial.” Clin Endocrinol (Oxf), 2012. doi:10.1111/j.1365-2265.2012.04413.x (PMID 22512435)
  5. Killick R, et al. “The effects of testosterone on ventilatory responses in men with obstructive sleep apnea: a randomised, placebo-controlled trial.” J Sleep Res, 2013. doi:10.1111/jsr.12027 (PMID 23331844)
  6. Boers E, et al. “Projecting the 30-year burden of obstructive sleep apnoea in the USA: a prospective modelling study.” Lancet Respir Med, 2025. doi:10.1016/S2213-2600(25)00243-7 (PMID 40882656)
Medical disclaimer. This article is educational and is not medical advice. Laboratory results only mean something in the context of your full clinical picture. Interpret them with a physician who knows your training history, your medication and supplement use, and your symptoms. Nothing here is a recommendation to start, stop, or change any drug. Several compounds discussed are not approved for the uses described and carry real risk.

About Tony Huge

Tony Huge is a self-experimenter, biohacker, and founder of Enhanced Labs. He has spent over a decade researching and personally testing peptides, SARMs, anabolic compounds, nootropics, and longevity protocols. Tony’s mission is to push the boundaries of human potential through science, transparency, and direct experience. Follow his research at tonyhuge.is.